Panama, the First Country to Acquire Vaccine Against the Sincitial Virus for Pregnant Women and Older Adults

Panama received on Monday 87,520 doses of the respiratory syncicial virus (SRV) vaccine, which is used to prevent respiratory tract diseases caused by this germ, an official source reported. This vaccine, whose commercial name is Abrysvo, is applied to pregnant women, babies from birth and up to 6 months and people over 60 years of age, explained the head of the Ministry of Health (Minsa), Fernando Boyd Galindo, according to a statement from the…

The Minsa reported that the investment in this new vaccine is $3.5 million, and that the country has the infrastructure needed for its storage and distribution.